Interestingly, multiple studies have shown that high CXCL12 expression is part of an iCAF profile [18, 26], and our analysis of TCGA data shows that CXCL12 is highest amongst NSCLC patients with predominant CAF‐S1. This evidence concerns the gene CXCL12 and non-small cell lung carcinoma.